|

AI Model for Early Gastric Cancer Diagnosis Using Endoscopic Imaging

RECRUITINGSponsored by The First Affiliated Hospital of Soochow University
Actively Recruiting
SponsorThe First Affiliated Hospital of Soochow University
Started2026-05-01
Est. completion2026-12-01
Eligibility
Age18 Years – 80 Years
Healthy vol.Accepted

Summary

Early gastric cancer (EGC) is often difficult to detect accurately during endoscopic examination due to subtle morphological features and variability among endoscopists. Artificial intelligence (AI) has shown promise in improving diagnostic performance; however, most existing models lack interpretability and rely on single-modality imaging. This study aims to develop and evaluate an explainable multimodal artificial intelligence model for the diagnosis of early gastric cancer using endoscopic imaging. The model integrates features derived from white-light imaging and image-enhanced endoscopy, along with quantitative image features and clinical data, to improve diagnostic accuracy and provide interpretable decision support. The primary outcome is the diagnostic performance of the AI model for detecting early gastric cancer, evaluated by area under the receiver operating characteristic curve (AUROC), sensitivity, and specificity. The results of this study are expected to provide evidence for the clinical utility of explainable AI in endoscopic diagnosis and support the development of reliable human-AI collaborative diagnostic systems.

Eligibility

Age: 18 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

* Age ≥18 years
* Suspicious gastric lesions identified on white-light imaging (WLI)
* Preoperative biopsy indicating precancerous lesions (dysplasia or intraepithelial neoplasia) or adenocarcinoma, with preoperative magnifying endoscopy with narrow-band imaging (ME-NBI) performed
* Patients meeting the absolute indications for endoscopic submucosal dissection (ESD) and who underwent ESD

Exclusion Criteria:

* Non-adenocarcinoma histological types (e.g., lymphoma)
* Patients who did not undergo ME-NBI examination or did not receive ESD
* Lesions invading the muscularis propria or deeper layers
* Missing or indeterminate postoperative histopathological results

Conditions2

CancerEarly Gastric Cancer

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.